32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Stratifying septic patients using lactate: severe sepsis and cryptic, vasoplegic and dysoxic shock profile

      abstract
      1 , 2 , , 1 , 3 , 1 , 1 , 3 , 4 , 1
      Critical Care
      BioMed Central
      Sepsis 2013
      5-6 November 2013

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background The current consensus definition of severe sepsis and septic shock includes a heterogeneous profile of patients under the same definition. Although the prognostic value of hyperlactatemia in sepsis is well established, hyperlactatemia can be found both in severe sepsis and septic shock patients. We sought to compare features and outcomes of septic patients stratified by two factors: the presence of hyperlactemia and persistent hypotension. Materials and methods This was a secondary analysis of a multicenter observational study from 10 private hospitals in Brazil (Rede Amil-SP) aiming to evaluate the impact of a multifaceted program to implement the Surviving Sepsis Campaign bundles. We retrieved 1,948 septic patients with an initial lactate level collected within the first 6 hours of diagnosis. Based on previous literature, we stratified them into four groups according to the presence of hypoperfusion (lactate >4 mmol/l) and/or persistent hypotension despite adequate fluids: 1, severe sepsis (without both criteria); 2, cryptic shock (hypoperfusion without persistent hypotension) [1]; 3, vasoplegic shock (persistent hypotension without hypoperfusion); and 4, dysoxic shock (with both criteria) [2]. Results Severe sepsis was found in 1,018 (52%), cryptic shock in 162 (8%), vasoplegic shock in 549 (28%) and dysoxic shock in 219 (12%) patients. Mean age was 60 years, 47% were male and the majority was admitted form the emergency department (47%). The lung was the principal source of infection, followed by the urinary tract and abdominal. Overall, the four groups presented significant differences in APACHE II and SOFA scores (P < 0.001 for both), dysoxic shock being the most severe group. In post-hoc analysis, patients in the severe sepsis group presented similar SOFA score to patients in the cryptic shock group (P = 0.20). Overall, 28-day crude survival was different between groups (P < 0.001), being higher for the severe sepsis group (69%, P < 0.001 vs. other), similar between cryptic and vasoplegic shock (53%, P = 0.39) and lower for dysoxic shock (38%, P < 0.001 vs. other). In an adjusted analysis considering age, APACHE II and SOFA, the 28-day survival remained different between groups (P < 0.001) and the hazard ratio for the dysoxic shock group was the highest: HR 2.99 (95% CI 2.21 to 4.05). Conclusions Current definitions for severe sepsis and septic shock include four different phenotypes, which should be considered for epidemiology purposes, customizing treatment goals and inclusion criteria for future studies. Although previous studies showed similar outcomes between cryptic shock and overt septic shock (vasoplegic and dysoxic profile), we demonstrated that cryptic shock is similar only to vasoplegic shock.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock.

          The current consensus definition of septic shock requires hypotension after adequate fluid challenge or vasopressor requirement. Some patients with septic shock present with hypotension and hyperlactatemia greater than 2 mmol/L (tissue dysoxic shock), whereas others have hypotension alone with normal lactate (vasoplegic shock). The objective of this study was to determine differences in outcomes of patients with tissue dysoxic versus vasoplegic septic shock. This was a secondary analysis of a large, multicenter randomized controlled trial. Inclusion criteria were suspected infection, two or more systemic inflammatory response criteria, and systolic blood pressure less than 90 mmHg after a fluid bolus. Patients were categorized by presence of vasoplegic or tissue dysoxic shock. Demographics and Sequential Organ Failure Assessment scores were evaluated between the groups. The primary outcome was in-hospital mortality. A total of 247 patients were included, 90 patients with vasoplegic shock and 157 with tissue dysoxic shock. There were no significant differences in age, race, or sex between the vasoplegic and tissue dysoxic shock groups. The group with vasoplegic shock had a lower initial Sequential Organ Failure Assessment score than did the group with tissue dysoxic shock (5.5 vs. 7.0 points; P = 0.0002). The primary outcome of in-hospital mortality occurred in 8 (9%) of 90 patients with vasoplegic shock compared with 41 (26%) of 157 in the group with tissue dysoxic shock (proportion difference, 17%; 95% confidence interval, 7%-26%; P < 0.0001; log-rank test P = 0.02). After adjusting for confounders, tissue dysoxic shock remained an independent predictor of in-hospital mortality. In this analysis of patients with septic shock, we found a significant difference in in-hospital mortality between patients with vasoplegic versus tissue dysoxic septic shock. These findings suggest a need to consider these differences when designing future studies of septic shock therapies.
            Bookmark

            Author and article information

            Conference
            Crit Care
            Crit Care
            Critical Care
            BioMed Central
            1364-8535
            1466-609X
            2013
            5 November 2013
            : 17
            : Suppl 4
            : P37
            Affiliations
            [1 ]Hospital Paulistano, São Paulo, Brazil
            [2 ]Disciplina de Emergências Clínicas, Hospital das Clínicas, Universidade de São Paulo, Brazil
            [3 ]Latin America Sepsis Institute, São Paulo, Brazil
            [4 ]Disciplina de Anestesiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil
            Article
            cc12937
            10.1186/cc12937
            3952647
            dcc54155-0b4c-4ec7-bbd7-783d0ce11913
            Copyright © 2013 Ranzani et al.; licensee BioMed Central Ltd.

            This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

            Sepsis 2013
            Rio de Janeiro, Brazil
            5-6 November 2013
            History
            Categories
            Poster Presentation

            Emergency medicine & Trauma
            Emergency medicine & Trauma

            Comments

            Comment on this article